enters talks about pay. hello and welcome to our look ahead to what the the papers will be bringing us tomorrow. with me are the business journalist, john crowley, and joe twyman, who s the director of the polling organisation, deltapoll. tomorrow s front pages, starting with. the financial times leads with covid cases in china, which the paper says have reached up to 250 million in december since the country eased lockdown restrictions. the times reports on an initiative by the government to cut down early retirement the paper says prime minister rishi sunak plans a midlife mot to get over 50s into work. the daily mail says the nhs is wasting money on equality, diversity and inclusion related positions. the i leads on yesterday s vote in scotland on gender identification reforms, saying it could lead to what it calls an unprecedented constitutional clash with westminster. it s also on the front page of the telegraph, which says labour leader sir keir starmer wants updated
what is only eight people have died out of what is reported to be 250 million infections. what is reported to be 250 million infections, seems ambitious, shall we say. infections, seems ambitious, shall we say. and infections, seems ambitious, shall we say, and the risk to the chinese population. we say, and the risk to the chinese population, which has been reported, is particularly to older people who have not is particularly to older people who have not been vaccinated in anything like that have not been vaccinated in anything like that kind of numbers we saw in this country like that kind of numbers we saw in this country and others, but also there this country and others, but also there is this country and others, but also there is a this country and others, but also there is a risk that the chinese vaccine there is a risk that the chinese vaccine is there is a risk that the chinese vaccine is again reportedly not as effective vaccine is again reportedly no
Eritrea continues to maintain the highest immunization coverage. According to a report by the UNICEF, Eritrea registered significant increase in vaccine intake in 2020 as compared to 2019, which is an increase of 14% immunization coverage. The succe
G ist nicht gleich G heise.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from heise.de Daily Mail and Mail on Sunday newspapers.
Curevac-Impfstoff erreicht offenbar nur schwache Wirksamkeit gegen Corona
Ziele in Zwischenstudie verfehlt
:
Corona-Impfstoff von Curevac erreicht nur 47-prozentige Wirksamkeit
Impfstoff der Tübinger Pharmafirma Curevac, die mit Bayer zusammenarbeitet (Symbolbild).
Foto: dpa /SVEN SIMON
Tübingen Der Corona-Impfstoffkandidat der Tübinger Pharmafirma Curevac galt lange als vielversprechend. Umso größer ist nun die Enttäuschung nach der Bekanntgabe neuester Daten zur Wirksamkeit des potenziellen Vakzins.
Drucken
Im Bemühen um die Markteinführung eines hochwirksamen Corona-Impfstoffs hat das Tübinger Pharmaunternehmen Curevac einen schweren Rückschlag erlitten. Der eigene Impfstoffkandidat CVnCoV habe einer Zwischenanalyse zufolge nur eine vorläufige Wirksamkeit von 47 Prozent gegen eine Corona-Erkrankung „jeglichen Schweregrades“ erzielt und damit nicht die vorgegebenen statistischen Erfolgskriterien erreicht, teilte das Unternehmen am Mittwochabend in einer Pflic